Physician

Somprak Boonpongmanee, M.D.

According to 2025 Medicare claims, Somprak Boonpongmanee, M.D. (NPI: 1528139359) practices gastroenterology in the Kennewick-Richland, WA market, with the plurality of this provider's patient population coming from Benton, WA. This provider's primary affiliated billing organization is TRI-CITIES DIGESTIVE HEALTH CENTER, PS (NPI: 1003987868; TIN: 911937537) and primary practice location at 99336-7193. Boonpongmanee is affiliated with the AdvantagePoint Health Alliance - Northwest, LLC (ACO ID: A5025), participating under the MSSP model.

Boonpongmanee's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 493 traditional Medicare patients, billed 36,469 HCPCS/CPT codes, and received $758,723 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 351 prescription claims across 177 beneficiaries totaling $695,583 in drug costs, led by Stelara (Ustekinumab). 2021 DME data shows 13 claims. Open Payments data shows 2 records totaling $201. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $273,878 to $758,723. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $215,066 and ending at $695,583. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	828	5,218	$273,878
2016	941	5,317	$288,301
2017	969	9,130	$317,166
2018	964	6,278	$322,851
2019	806	7,048	$339,907
2020	741	17,291	$531,030
2021	810	18,686	$546,150
2022	799	26,352	$668,137
2023	584	30,925	$691,014
2024	493	36,469	$758,723

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	348	1,603	$215,066
2016	330	1,337	$219,567
2017	305	979	$161,617
2018	350	1,121	$243,548
2019	302	961	$136,327
2020	292	819	$115,591
2021	390	1,024	$128,455
2022	282	708	$211,220
2023	199	501	$591,378
2024	177	351	$695,583

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	34	$414
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	11	$219
2019	N/R	11	$167
2020	N/R	25	$553
2021	N/R	13	$259
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	220	225	$218
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	65	80	$93
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	112	117	$89
88305	Pathology examination of tissue using a microscope, intermediate complexity	293	550	$28
G0500	Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito	244	276	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Stelara	Ustekinumab	23	672	$589,436
Mesalamine	Mesalamine	22	1,196	$25,223
Sod Sulf-Potass Sulf-Mag Sulf	Sodium, Potassium,mag Sulfates	17	25	$1,065
Esomeprazole Magnesium	Esomeprazole Magnesium	29	2,038	$860
Pantoprazole Sodium	Pantoprazole Sodium	50	3,720	$855

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$201	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Somprak Boonpongmanee, M.D.?

Tedicare shows public-source Medicare data for Somprak Boonpongmanee, M.D. (NPI 1528139359), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Somprak Boonpongmanee, M.D. have ACO affiliation data?

Somprak Boonpongmanee, M.D. is shown with ACO affiliation data for AdvantagePoint Health Alliance - Northwest, LLC (MSSP, ACO ID A5025).

What billing organization is linked to Somprak Boonpongmanee, M.D.?

Somprak Boonpongmanee, M.D. is linked to TRI-CITIES DIGESTIVE HEALTH CENTER, PS (billing NPI 1003987868) in the available physician profile data.

Does Somprak Boonpongmanee, M.D. have Open Payments data?

Somprak Boonpongmanee, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.